Withdrawal from Chronic Intermittent Ethanol Treatment Changes Subunit Composition, Reduces Synaptic Function, and Decreases Behavioral Responses to Positive Allosteric Modulators of GABAA Receptors
- 1 January 2003
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 63 (1) , 53-64
- https://doi.org/10.1124/mol.63.1.53
Abstract
One of the pharmacological targets of ethanol is the GABAAreceptor (GABAR), whose function and expression are altered after chronic administration of ethanol. The details of the changes differ between experimental models. In the chronic intermittent ethanol (CIE) model for alcohol dependence, rats are exposed to intermittent episodes of intoxicating ethanol and withdrawal, leading to a kindling-like state of behavioral excitability. This is accompanied by presumably causal changes in GABAR expression and physiology. The present study investigates further the effect of CIE on GABAR function and expression. CIE is validated as a model for human alcohol withdrawal syndrome (AWS) by demonstrating increased level of anxiety; diazepam improved performance in the test. In addition, CIE rats showed remarkably reduced hypnotic response to a benzodiazepine and a steroid anesthetic, reduced sensitivity to a barbiturate, but not propofol. Immunoblotting revealed decrease in α1 and δ expression and increase in γ2 and α4 subunits in hippocampus of CIE rats, confirmed by an increase in diazepam-insensitive binding for ethyl-8-azido-5,6-dihydro-5-methyl-6-oxo-4H-imidazo(1,5-α)(1,4)benzodiazepine-3-carboxylate (Ro15-4513). Elevated mRNA levels were shown for the γ2S and γ1 subunits. Recordings in hippocampal slices from CIE rats revealed that the decay time of GABAR-mediated miniature inhibitory postsynaptic currents (mIPSCs) in CA1 pyramidal cells was decreased, and potentiation of mIPCSs by positive modulators of GABAR was also reduced compared with control rats. However, mIPSC potentiation by the α4-preferring benzodiazepine ligands bretazenil and Ro15-4513 was maintained, and increased, respectively. These data suggest that specific alterations in GABAR occur after CIE and may underlie the development of hyperexcitability and ethanol dependence.Keywords
This publication has 34 references indexed in Scilit:
- Pharmacological characterization of a novel cell line expressing human α4β3δ GABAA receptorsBritish Journal of Pharmacology, 2002
- Molecular and Neuronal Substrate for the Selective Attenuation of AnxietyScience, 2000
- Quantification of relative mRNA expression in the rat brain using simple RT-PCR and ethidium bromide stainingJournal of Neuroscience Methods, 2000
- Alteration in the Sensitivity of GABAAReceptors to Allosteric Modulatory Drugs in Rat Hippocampus After Chronic Intermittent Ethanol TreatmentAlcohol, Clinical and Experimental Research, 1998
- Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsyNature Medicine, 1998
- Bidirectional Alterations of GABAA Receptor Subunit Peptide Levels in Rat Cortex During Chronic Ethanol Consumption and WithdrawalJournal of Neurochemistry, 1997
- Persistent reduction of GABAA receptor-mediated inhibition in rat hippocampus after chronic intermittent ethanol treatmentBrain Research, 1996
- The Kindling Model of Alcohol Dependence: Similar Persistent Reduction in Seizure Threshold to Pentylenetetrazol in Animals Receiving Chronic Ethanol or Chronic PentylenetetrazolAlcohol, Clinical and Experimental Research, 1993
- Acute and chronic ethanol treatments alter GABA receptor-operated chloride channelsPharmacology Biochemistry and Behavior, 1987
- Tolerance to and cross-tolerance among ethanol, pentobarbital and chlordiazepoxidePharmacology Biochemistry and Behavior, 1986